Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection

被引:75
作者
Zhao, XP
Tang, ZY
Klumpp, B
Wolff-Vorbeck, G
Barth, H
Levy, S
von Weizsäcker, F
Blum, HE
Baumert, TF
机构
[1] Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany
[2] Univ Freiburg, Dept Surg, D-79106 Freiburg, Germany
[3] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA 94305 USA
关键词
D O I
10.1172/JCI200213011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hepatitis C virus (HCV) is a major cause of chronic hepatitis worldwide, but the study of HCV infection has been hampered by the lack of an in vitro or in vivo small animal model. The tree shrew Tupaia belangeri is susceptible to infection with a variety of human viruses in vivo, including hepatitis viruses. We show that primary Tupaia hepatocytes can be infected with serum- or plasma-derived HCV from infected humans, as measured by de novo synthesis of HCV RNA, analysis of viral quasispecies evolution, and detection of viral proteins. Production of infectious virus could be demonstrated by passage to naive hepatocytes. To assess whether viral entry in Tupaia hepatocytes was dependent on the recently isolated HCV E2 binding protein CD81, we identified and characterized Tupaia CD81. Sequence analysis of cloned Tupaia cDNA revealed a high degree of homology between Tupaia and human CD8 I large extracellular loops (LEL). Cellular binding of E2 and HCV infection could not be inhibited by anti-CD81 antibodies or soluble CD81-LEL, suggesting that viral entry can occur through receptors other than CD81. Thus, primary Tupaia hepatocytes provide a potential model for the study of HCV infection of hepatocytes.
引用
收藏
页码:221 / 232
页数:12
相关论文
共 50 条
[41]   EVIDENCE FOR INVITRO REPLICATION OF HEPATITIS-C VIRUS GENOME IN A HUMAN T-CELL LINE [J].
SHIMIZU, YK ;
IWAMOTO, A ;
HIJIKATA, M ;
PURCELL, RH ;
YOSHIKURA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5477-5481
[42]  
TANG ZY, 1999, 6 INT M HEP C REL VI
[43]   CLINICAL OUTCOMES AFTER TRANSFUSION-ASSOCIATED HEPATITIS-C [J].
TONG, MJ ;
ELFARRA, NS ;
REIKES, AR ;
CO, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1463-1466
[44]  
Wack A, 2001, EUR J IMMUNOL, V31, P166, DOI 10.1002/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO
[45]  
2-L
[46]   Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo [J].
Walter, E ;
Keist, R ;
Niederost, B ;
Pult, I ;
Blum, HE .
HEPATOLOGY, 1996, 24 (01) :1-5
[47]   Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor [J].
Wünschmann, S ;
Medh, JD ;
Klinzmann, D ;
Schmidt, WN ;
Stapleton, JT .
JOURNAL OF VIROLOGY, 2000, 74 (21) :10055-10062
[48]   Transmission of hepatitis C virus infection to tree shrews [J].
Xie, ZC ;
Riezu-Boj, JI ;
Lasarte, JJ ;
Guillen, J ;
Su, JH ;
Civeira, MP ;
Prieto, J .
VIROLOGY, 1998, 244 (02) :513-520
[49]   Human hepatitis B virus and hepatocellular carcinoma .1. Experimental infection of tree shrews with hepatitis B virus [J].
Yan, RQ ;
Su, JJ ;
Huang, DR ;
Gan, YC ;
Yang, C ;
Huang, GH .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (05) :283-288
[50]   Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee [J].
Yanagi, M ;
Purcell, RH ;
Emerson, SU ;
Bukh, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8738-8743